160 related articles for article (PubMed ID: 32451170)
1. Oral squamous cell carcinoma of the tongue dorsum with multiple cancer-associated mutations in the TP53 gene.
Yamasaki S; Tani R; Sakurai S; Toratani S; Okamoto T
Oral Oncol; 2020 Oct; 109():104774. PubMed ID: 32451170
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.
Ono S; Hirose K; Sukegawa S; Obata K; Masui M; Hasegawa K; Fujimura A; Shimada K; Nakamura S; Teramoto A; Hori Y; Morii E; Motooka D; Igawa T; Tanaka T; Nagatsuka H; Toyosawa S; Yamamoto H
Diagn Pathol; 2024 Apr; 19(1):63. PubMed ID: 38650013
[TBL] [Abstract][Full Text] [Related]
3. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
4. Absence of p53 mutations in squamous carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years.
Sorensen DM; Lewark TM; Haney JL; Meyers AD; Krause G; Franklin WA
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):503-6. PubMed ID: 9158397
[TBL] [Abstract][Full Text] [Related]
5. TP53 Pro72 allele is enriched in oral tongue cancer and frequently mutated in esophageal cancer in India.
Adduri RS; Katamoni R; Pandilla R; Madana SN; Paripati AK; Kotapalli V; Bashyam MD
PLoS One; 2014; 9(12):e114002. PubMed ID: 25436609
[TBL] [Abstract][Full Text] [Related]
6. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
Kashofer K; Regauer S
Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the dorsum of the tongue.
Goldenberg D; Ardekian L; Rachmiel A; Peled M; Joachims HZ; Laufer D
Head Neck; 2000 Mar; 22(2):190-4. PubMed ID: 10679909
[TBL] [Abstract][Full Text] [Related]
8. Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers.
Faden DL; Arron ST; Heaton CM; DeRisi J; South AP; Wang SJ
J Otolaryngol Head Neck Surg; 2016 Sep; 45(1):47. PubMed ID: 27640185
[TBL] [Abstract][Full Text] [Related]
9. TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas.
Högmo A; Börresen-Dale AL; Blegen H; Lindholm J; Kuylenstierna R; Auer G; Munck-Wikland E
Anticancer Res; 1999; 19(4C):3433-8. PubMed ID: 10629631
[TBL] [Abstract][Full Text] [Related]
10. Granular cell tumor mimicking a squamous cell carcinoma of the tongue: a case report.
Ferreira JC; Oton-Leite AF; Guidi R; Mendonça EF
BMC Res Notes; 2017 Jan; 10(1):14. PubMed ID: 28057062
[TBL] [Abstract][Full Text] [Related]
11. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.
Sano D; Xie TX; Ow TJ; Zhao M; Pickering CR; Zhou G; Sandulache VC; Wheeler DA; Gibbs RA; Caulin C; Myers JN
Clin Cancer Res; 2011 Nov; 17(21):6658-70. PubMed ID: 21903770
[TBL] [Abstract][Full Text] [Related]
12. TP53 gene expression in HPV-positive oral tongue SCC and its correlation with nodal metastasis.
Seraj JM; Yazdani N; Ashtiani ZO; Seraj SM; Hasheminasab SM; Memar B; Mirashrafi F; Borghei H; Yazdani J; Mostaan LV
Pathol Res Pract; 2011 Dec; 207(12):758-61. PubMed ID: 22055991
[TBL] [Abstract][Full Text] [Related]
13. Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke.
Li R; Faden DL; Fakhry C; Langelier C; Jiao Y; Wang Y; Wilkerson MD; Pedamallu CS; Old M; Lang J; Loyo M; Ahn SM; Tan M; Gooi Z; Chan J; Richmon J; Wood LD; Hruban RH; Bishop J; Westra WH; Chung CH; Califano J; Gourin CG; Bettegowda C; Meyerson M; Papadopoulos N; Kinzler KW; Vogelstein B; DeRisi JL; Koch WM; Agrawal N
Head Neck; 2015 Nov; 37(11):1642-9. PubMed ID: 24954188
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
[TBL] [Abstract][Full Text] [Related]
15. Survivin gene polymorphism association with tongue squamous cell carcinoma.
Mostaan LV; Tabari A; Amiri P; Ashtiani MK; Mahdkhah A; Yazdani N; Khaniki M; Tabari A; Tavakkoly-Bazzaz J; Amoli MM
Genet Test Mol Biomarkers; 2013 Jan; 17(1):74-7. PubMed ID: 23176035
[TBL] [Abstract][Full Text] [Related]
16. Nuclear DNA content and p53 overexpression in stage I squamous cell carcinoma of the tongue compared with advanced tongue carcinomas.
Högmo A; Kuylenstierna R; Lindholm J; Nathansson A; Auer G; Munck-Wikland E
Mol Pathol; 1998 Oct; 51(5):268-72. PubMed ID: 10193521
[TBL] [Abstract][Full Text] [Related]
17. "MYH9 mutation and squamous cell cancer of the tongue in a young adult: a novel case report".
Yabe TE; King K; Russell S; Satgunaseelan L; Gupta R; Chen J; Ashford B
Diagn Pathol; 2022 Feb; 17(1):23. PubMed ID: 35125114
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma cuniculatum of the esophagus and tongue: report of two cases, including TP53 mutational analysis.
Goh GH; Venkateswaran K; Leow PC; Loh KS; Thamboo TP; Petersson F
Head Neck Pathol; 2014; 8(3):261-8. PubMed ID: 24470056
[TBL] [Abstract][Full Text] [Related]
19. High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue.
Otsuka Y; Sato H; Oikawa T; Onodera Y; Nam JM; Hashimoto A; Fukunaga K; Hatanaka KC; Hatanaka Y; Matsuno Y; Fukuda S; Sabe H
Cell Commun Signal; 2016 Nov; 14(1):28. PubMed ID: 27871329
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study.
Nagler RM; Kerner H; Laufer D; Ben-Eliezer S; Minkov I; Ben-Itzhak O
Cancer Lett; 2002 Dec; 186(2):137-50. PubMed ID: 12213283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
